S9562 Home injectable therapy, palivizumab or other monoclonal antibody for rsv, including administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem
Short descriptor: Ht inj palivizumab/ab diem
Look up S9562 alongside ICD-10-CM diagnoses, the HCPCS Table of Drugs, and the AI coding assistant.
S9562 is the HCPCS Level II code for Home injectable therapy, palivizumab or other monoclonal antibody for rsv, including administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem (2026). It belongs to Section S — Temporary National Codes (Non-Medicare). Under Medicare, its coverage status is: Not payable by Medicare. Part B pricing methodology: Not separately priced by Part B.
Classification & CMS Attributes
- Medicare Coverage
- Not payable by Medicare (code I)
- Part B Pricing
- Not separately priced by Part B (indicator 00)
- Type of Service
- Other medical items or services
- Effective Date
- 2023-04-01
- 2026 Maintenance
- No change this year
References
Cite This Page
Reference S9562 with the canonical source and edition:
S9562 — Home injectable therapy, palivizumab or other monoclonal antibody for rsv, including administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem. ICD-10 Coding Pro (HCPCS Level II 2026). https://icd10codingpro.com/hcpcs-codes/S9562
Canonical URL: https://icd10codingpro.com/hcpcs-codes/S9562